ID

44127

Descrizione

Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00590603

collegamento

https://clinicaltrials.gov/show/NCT00590603

Keywords

versioni (2)
  1. 26/06/18 26/06/18 -
  2. 20/09/21 20/09/21 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

20 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Multiple Myeloma NCT00590603

Inglese

Eligibility Multiple Myeloma NCT00590603

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of relapsed/refractory multiple myeloma.
Descrizione

Recurrent multiple myeloma | Refractory multiple myeloma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1370446
UMLS CUI [2]
C0278620
patients must have measurable disease, defined as localized plasmacytoma, detectable m-spike by serum protein electrophoresis (spep) and/or urine protein electrophoresis (upep), or free light chain assay, bone lytic lesions and/or bone marrow infiltration with atypical plasma-cells.
Descrizione

Measurable Disease | Plasmacytoma Localized | m-spike Serum protein electrophoresis | m-spike Urine protein electrophoresis | Free Immunoglobulin Light Chain Assay | Osteolytic lesion | Bone marrow infiltration Plasma Cells Atypical

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0032131
UMLS CUI [2,2]
C0392752
UMLS CUI [3,1]
C0241988
UMLS CUI [3,2]
C0201720
UMLS CUI [4,1]
C0241988
UMLS CUI [4,2]
C0201721
UMLS CUI [5,1]
C0806492
UMLS CUI [5,2]
C1510438
UMLS CUI [6]
C0302313
UMLS CUI [7,1]
C3854434
UMLS CUI [7,2]
C0032112
UMLS CUI [7,3]
C0205182
patients must be at least four weeks since their prior therapy. patients will not be excluded because of any prior regimen they have received as long as they meet other requirements.
Descrizione

Prior Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1514463
adequate organ function, patients with elevated creatinine due to myeloma are not excluded
Descrizione

Organ function | Serum creatinine raised Due to Myeloma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0700225
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0026764
eastern cooperative oncology group (ecog) performance status 0-2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
serum potassium greater than 4.0 milliequivalent (meq)/dl and serum magnesium greater than 1.8 mg/dl. if these electrolytes are below the specified limits on the baseline laboratory tests, supplemental electrolytes should be administered to bring the serum concentrations to these levels before administering arsenic trioxide.
Descrizione

Serum potassium measurement | Serum magnesium measurement | Electrolytes Supplemental As Needed | Arsenic trioxide

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0302353
UMLS CUI [2]
C0202125
UMLS CUI [3,1]
C0013832
UMLS CUI [3,2]
C2348609
UMLS CUI [3,3]
C1720688
UMLS CUI [4]
C0052416
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients may not be receiving any other investigational agents.
Descrizione

Investigational New Drugs Other

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0205394
history of allergic reactions attributed to compounds of similar chemical or biologic composition to bortezomib, trisenox, ascorbic acid, or other agents used in the study.
Descrizione

Allergic Reaction Compound Bortezomib Similar | Allergic Reaction Compound Trisenox Similar | Allergic Reaction Compound Ascorbic Acid Similar | Allergic Reaction Compound Investigational New Drugs Similar

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C1706082
UMLS CUI [1,3]
C1176309
UMLS CUI [1,4]
C2348205
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C1706082
UMLS CUI [2,3]
C1096917
UMLS CUI [2,4]
C2348205
UMLS CUI [3,1]
C1527304
UMLS CUI [3,2]
C1706082
UMLS CUI [3,3]
C0003968
UMLS CUI [3,4]
C2348205
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C1706082
UMLS CUI [4,3]
C0013230
UMLS CUI [4,4]
C2348205
corrected qt interval (qtc) interval greater than 460 msec in the presence of serum potassium greater than or equal to 4.0 meq/l and magnesium greater than or equal to 1.8 mg/dl, or underlying conduction disease that prevents measurement of the qtc interval.
Descrizione

Prolonged QTc interval | Serum potassium measurement | Serum magnesium measurement | Conduction disorder Preventing QTc interval Measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1560305
UMLS CUI [2]
C0302353
UMLS CUI [3]
C0202125
UMLS CUI [4,1]
C0264886
UMLS CUI [4,2]
C1292733
UMLS CUI [4,3]
C0489625
UMLS CUI [4,4]
C0242485
history of ventricular tachycardia or any cardiac arrhythmia requiring the placement of an automated intraventricular cardiac defibrillator or therapy with class i or class ii antiarrhythmic drug.
Descrizione

Tachycardia, Ventricular | Cardiac Arrhythmia Requirement Automatic Implantable Cardioverter-Defibrillators | Cardiac Arrhythmia Requirement Anti-Arrhythmia Agents Class

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0042514
UMLS CUI [2,1]
C0003811
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0972395
UMLS CUI [3,1]
C0003811
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C0003195
UMLS CUI [3,4]
C0456387
ejection fraction (ef) by multigated acquisition (muga) scan less than 35%.
Descrizione

Cardiac ejection fraction MUGA scan

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0521317
Ritorna all'inizio della pagina

Similar models

Eligibility Multiple Myeloma NCT00590603

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Recurrent multiple myeloma | Refractory multiple myeloma
Item
diagnosis of relapsed/refractory multiple myeloma.
boolean
C1370446 (UMLS CUI [1])
C0278620 (UMLS CUI [2])
Measurable Disease | Plasmacytoma Localized | m-spike Serum protein electrophoresis | m-spike Urine protein electrophoresis | Free Immunoglobulin Light Chain Assay | Osteolytic lesion | Bone marrow infiltration Plasma Cells Atypical
Item
patients must have measurable disease, defined as localized plasmacytoma, detectable m-spike by serum protein electrophoresis (spep) and/or urine protein electrophoresis (upep), or free light chain assay, bone lytic lesions and/or bone marrow infiltration with atypical plasma-cells.
boolean
C1513041 (UMLS CUI [1])
C0032131 (UMLS CUI [2,1])
C0392752 (UMLS CUI [2,2])
C0241988 (UMLS CUI [3,1])
C0201720 (UMLS CUI [3,2])
C0241988 (UMLS CUI [4,1])
C0201721 (UMLS CUI [4,2])
C0806492 (UMLS CUI [5,1])
C1510438 (UMLS CUI [5,2])
C0302313 (UMLS CUI [6])
C3854434 (UMLS CUI [7,1])
C0032112 (UMLS CUI [7,2])
C0205182 (UMLS CUI [7,3])
Prior Therapy
Item
patients must be at least four weeks since their prior therapy. patients will not be excluded because of any prior regimen they have received as long as they meet other requirements.
boolean
C1514463 (UMLS CUI [1])
Organ function | Serum creatinine raised Due to Myeloma
Item
adequate organ function, patients with elevated creatinine due to myeloma are not excluded
boolean
C0678852 (UMLS CUI [1])
C0700225 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0026764 (UMLS CUI [2,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Serum potassium measurement | Serum magnesium measurement | Electrolytes Supplemental As Needed | Arsenic trioxide
Item
serum potassium greater than 4.0 milliequivalent (meq)/dl and serum magnesium greater than 1.8 mg/dl. if these electrolytes are below the specified limits on the baseline laboratory tests, supplemental electrolytes should be administered to bring the serum concentrations to these levels before administering arsenic trioxide.
boolean
C0302353 (UMLS CUI [1])
C0202125 (UMLS CUI [2])
C0013832 (UMLS CUI [3,1])
C2348609 (UMLS CUI [3,2])
C1720688 (UMLS CUI [3,3])
C0052416 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs Other
Item
patients may not be receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Allergic Reaction Compound Bortezomib Similar | Allergic Reaction Compound Trisenox Similar | Allergic Reaction Compound Ascorbic Acid Similar | Allergic Reaction Compound Investigational New Drugs Similar
Item
history of allergic reactions attributed to compounds of similar chemical or biologic composition to bortezomib, trisenox, ascorbic acid, or other agents used in the study.
boolean
C1527304 (UMLS CUI [1,1])
C1706082 (UMLS CUI [1,2])
C1176309 (UMLS CUI [1,3])
C2348205 (UMLS CUI [1,4])
C1527304 (UMLS CUI [2,1])
C1706082 (UMLS CUI [2,2])
C1096917 (UMLS CUI [2,3])
C2348205 (UMLS CUI [2,4])
C1527304 (UMLS CUI [3,1])
C1706082 (UMLS CUI [3,2])
C0003968 (UMLS CUI [3,3])
C2348205 (UMLS CUI [3,4])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C0013230 (UMLS CUI [4,3])
C2348205 (UMLS CUI [4,4])
Prolonged QTc interval | Serum potassium measurement | Serum magnesium measurement | Conduction disorder Preventing QTc interval Measurement
Item
corrected qt interval (qtc) interval greater than 460 msec in the presence of serum potassium greater than or equal to 4.0 meq/l and magnesium greater than or equal to 1.8 mg/dl, or underlying conduction disease that prevents measurement of the qtc interval.
boolean
C1560305 (UMLS CUI [1])
C0302353 (UMLS CUI [2])
C0202125 (UMLS CUI [3])
C0264886 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0489625 (UMLS CUI [4,3])
C0242485 (UMLS CUI [4,4])
Tachycardia, Ventricular | Cardiac Arrhythmia Requirement Automatic Implantable Cardioverter-Defibrillators | Cardiac Arrhythmia Requirement Anti-Arrhythmia Agents Class
Item
history of ventricular tachycardia or any cardiac arrhythmia requiring the placement of an automated intraventricular cardiac defibrillator or therapy with class i or class ii antiarrhythmic drug.
boolean
C0042514 (UMLS CUI [1])
C0003811 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0972395 (UMLS CUI [2,3])
C0003811 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0003195 (UMLS CUI [3,3])
C0456387 (UMLS CUI [3,4])
Cardiac ejection fraction MUGA scan
Item
ejection fraction (ef) by multigated acquisition (muga) scan less than 35%.
boolean
C0232174 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial